Vanguard Personalized Indexing Management’s Integra LifeSciences IART Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,421	Closed	-$454K	–	1650
2023 Q4	$454K	Buy	+10,421	New	+$410K	0.01%	1046
2023 Q3	–	Sell	-5,193	Closed	-$214K	–	1513
2023 Q2	$214K	Sell	5,193 -1,925	-27%	-$92.6K	0.01%	1299
2023 Q1	$409K	Buy	+7,118	New	+$401K	0.01%	969
2021 Q4	–	Sell	-5,585	Closed	-$382K	–	1081
2021 Q3	$382K	Buy	+5,585	New	+$395K	0.03%	654

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Personalized Indexing Management's IART Position: Q1 2024 in Review

Vanguard Personalized Indexing Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 10,421 shares — an estimated $454K sold.

Vanguard Personalized Indexing Management first reported a position in IART in Q3 2021 and held it in 4 quarters. The position peaked at $454K in Q4 2023. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

Vanguard Personalized Indexing Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 10,421 Integra LifeSciences shares in Q1 2024, an estimated $454K.
Vanguard Personalized Indexing Management first reported a position in Integra LifeSciences in Q3 2021 and held it in 4 quarters.
Vanguard Personalized Indexing Management's Integra LifeSciences position peaked at $454K in Q4 2023.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2024, filed 9 May 2024.